273 related articles for article (PubMed ID: 32680534)
21. Hepatitis E Virus Seroprevalence Rate in HIV-Infected Patients in Germany: A Comparison of Two Commercial Assays.
Pischke S; Schwarze-Zander C; Bremer B; Lehmann P; Wiegand SB; Gisa A; Behrendt P; Strassburg CP; Manns MP; Wedemeyer H; Rockstroh JK
Intervirology; 2015; 58(5):283-7. PubMed ID: 26625157
[TBL] [Abstract][Full Text] [Related]
22. [Seroprevalence of hepatitis E virus in patients with hepatitis C and / or infected with HIV].
López-Fabal MF; Gómez-Garcés JL
Rev Esp Quimioter; 2015 Dec; 28(6):314-6. PubMed ID: 26621176
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis E in hemodialysis and kidney transplant patients in south-east Italy.
Scotto G; Aucella F; Grandaliano G; Martinelli D; Querques M; Gesuete A; Infante B; Carri PD; Massa S; Salatino G; Bulla F; Fazio V
World J Gastroenterol; 2015 Mar; 21(11):3266-73. PubMed ID: 25805933
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of antibodies and RNA genome of hepatitis E virus in a cohort of French immunocompromised.
Maylin S; Stephan R; Molina JM; Peraldi MN; Scieux C; Nicand E; Simon F; Delaugerre C
J Clin Virol; 2012 Apr; 53(4):346-9. PubMed ID: 22293627
[TBL] [Abstract][Full Text] [Related]
25. High seroprevalence of hepatitis E virus in the ethnic minority populations in Yunnan, China.
Feng Y; Feng YM; Wang S; Xu F; Zhang X; Zhang C; Jia Y; Yang W; Xia X; Yin J
PLoS One; 2018; 13(5):e0197577. PubMed ID: 29787589
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis E virus infection in haemodialysis patients: a case-control study in Saudi Arabia.
Ayoola EA; Want MA; Gadour MO; Al-Hazmi MH; Hamza MK
J Med Virol; 2002 Mar; 66(3):329-34. PubMed ID: 11793384
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis E Virus Seroprevalence and Correlates of Anti-HEV IgG Antibodies in the Rakai District, Uganda.
Boon D; Redd AD; Laeyendecker O; Engle RE; Nguyen H; Ocama P; Boaz I; Ndyanabo A; Kiggundu V; Reynolds SJ; Gray RH; Wawer MJ; Purcell RH; Kirk GD; Quinn TC; Stabinski L;
J Infect Dis; 2018 Feb; 217(5):785-789. PubMed ID: 29186448
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of anti-hepatitis E virus immunoglobulin G in HIV-infected individuals over three decades.
Harritshøj LH; Kirkegaard-Klitbo DM; Mejer N; Panum I; Midgley SE; Ullum H; Benfield T
Int J Infect Dis; 2019 Jul; 84():67-72. PubMed ID: 31063824
[TBL] [Abstract][Full Text] [Related]
29. Seroprevalence of hepatitis E virus in an adult urban population from Burundi.
Aubry P; Niel L; Niyongabo T; Kerguelen S; Larouze B
Am J Trop Med Hyg; 1997 Sep; 57(3):272-3. PubMed ID: 9311635
[TBL] [Abstract][Full Text] [Related]
30. HEV seroprevalence in blood donors in Turkey by two commercial total anti-HEV Ab ELISA kits.
Yaşar O; Karatayli E; Cengiz G; Kızılpınar M; Yurdcu E; Albayrak R; Güven A; Arslan Ö; Karahan C; Otlu B; Güdücüoğlu H; Gökahmetoğlu S; Berk E; Kirişci Ö; Sertöz R; Yurdaydin C; Bozdayi AM; Karatayli SC
J Med Virol; 2019 Dec; 91(12):2174-2181. PubMed ID: 31403185
[TBL] [Abstract][Full Text] [Related]
31. Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China.
Bai MJ; Zhou N; Dong W; Li GX; Cong W; Zhu XQ
Int J Infect Dis; 2018 Jun; 71():42-47. PubMed ID: 29656134
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis E virus seroprevalence and determinants in various study populations in the Netherlands.
Alberts CJ; Schim van der Loeff MF; Sadik S; Zuure FR; Beune EJAJ; Prins M; Snijder MB; Bruisten SM
PLoS One; 2018; 13(12):e0208522. PubMed ID: 30557324
[TBL] [Abstract][Full Text] [Related]
33. A Special Risk Group for Hepatitis E Infection: The First Record of North Cyprus.
Süer K; Güvenir M; Aykaç A
Pol J Microbiol; 2018; 67(4):525-528. PubMed ID: 30550239
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence for hepatitis E virus (HEV) infection among volunteer blood donors of the Regional Blood Bank of Londrina, State of Paraná , Brazil.
Bortoliero AL; Bonametti AM; Morimoto HK; Matsuo T; Reiche EM
Rev Inst Med Trop Sao Paulo; 2006; 48(2):87-92. PubMed ID: 16699630
[TBL] [Abstract][Full Text] [Related]
35. Seroprevalence and risk factors of Hepatitis E Virus infection among pregnant women in Addis Ababa, Ethiopia.
Abebe M; Ali I; Ayele S; Overbo J; Aseffa A; Mihret A
PLoS One; 2017; 12(6):e0180078. PubMed ID: 28650982
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012-2014).
Vázquez-Morón S; Berenguer J; González-García J; Jiménez-Sousa MÁ; Canorea I; Guardiola JM; Crespo M; Quereda C; Sanz J; Carrero A; Hontañón V; Avellón A; Resino S
Sci Rep; 2019 Feb; 9(1):1143. PubMed ID: 30718554
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis E seroprevalence in the United States: Results for immunoglobulins IGG and IGM.
Cangin C; Focht B; Harris R; Strunk JA
J Med Virol; 2019 Jan; 91(1):124-131. PubMed ID: 30168589
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and characteristics of hepatitis E virus infection in kidney transplant recipients: A single-center experience in Japan.
Nanmoku K; Owada Y; Oshiro Y; Kurosawa A; Kubo T; Shinzato T; Shimizu T; Kimura T; Sakuma Y; Ishikawa N; Ohkohchi N; Okamoto H; Yagisawa T
Transpl Infect Dis; 2019 Apr; 21(2):e13033. PubMed ID: 30481402
[TBL] [Abstract][Full Text] [Related]
39. High seroprevalence of hepatitis E virus in rabbit slaughterhouse workers.
Geng Y; Zhao C; Geng K; Wang C; Wang X; Liu H; Wang Y
Transbound Emerg Dis; 2019 Mar; 66(2):1085-1089. PubMed ID: 30661292
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis E seroprevalence and related risk factors among seafood processing workers: a cross-sectional survey in Shandong Province, China.
Cui W; Sun Y; Xu A; Gao R; Gong L; Zhang L; Jiang M
Int J Infect Dis; 2016 Aug; 49():62-6. PubMed ID: 27265612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
